Rosen Law Firm files Blaize securities suit over NeoTensr revenue
The Rosen Law Firm announced it filed the initial securities class action against Blaize Holdings, alleging improper revenue recognition from a $20 million NeoTensr deal. Kaplan Fox & Kilsheimer LLP has also joined the litigation. Investors in the July 2025-April 2026 class period are urged to seek counsel before the October 5, 2026, lead plaintiff deadline.

*this image is generated using AI for illustrative purposes only.
The Rosen Law Firm has announced that it filed the initial securities class action lawsuit on behalf of purchasers of Blaize Holdings, Inc. (NASDAQ: BZAI) securities between July 18, 2025, and April 28, 2026. The suit alleges that Blaize made false and misleading statements by announcing transactions with entities unequipped to conduct meaningful business, specifically citing a $20 million deal with NeoTensr that was improperly recognized as revenue to create an appearance of growth.
Kaplan Fox & Kilsheimer LLP has also joined the growing roster of plaintiffs' attorneys in the federal securities class action, intensifying legal pressure on the company. The litigation centers on the $20 million transaction with NeoTensr, a partner entity incorporated in December 2025, which Blaize recognized as Q4FY26 revenue despite the partner's limited operational history and approximately $2 million in startup capital. Following the disclosure of the controversy, Blaize's stock dropped 12.04% to close at $1.90 per share on April 28, 2026.
Legal Landscape and Competing Firms
The Rosen Law Firm states it was the first to file the action. Kaplan Fox’s entry adds to a competitive field of plaintiffs' counsel already representing investors in the case. Existing firms include Faruqi & Faruqi, LLP, Glancy Prongay Wolke & Rotter LLP, Pomerantz LLP, Bragar Eagel & Squire, P.C., Robbins LLP, The Law Offices of Frank R. Cruz, The Portnoy Law Firm, and Johnson Fistel, PLLP.
Rosen Law Firm highlights its ranking as No. 1 by ISS Securities Class Action Services for settlements in 2017 and its global recovery of billions for investors. Kaplan Fox is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has recovered more than $10 billion for clients, including a $2.425 billion recovery for Bank of America shareholders. Johnson Fistel, which recently joined the case, recovered approximately $90.7 million for aggrieved investors in 2024.
| Metric | Value |
|---|---|
| Class Period Start | July 18, 2025 |
| Class Period End | April 28, 2026 |
| Lead Plaintiff Deadline | October 5, 2026 |
| Alleged Revenue from NeoTensr (Q4) | $20 million |
| Expected Revenue from NeoTensr Deal | $50 million |
| Stock Drop on April 28, 2026 | 12.04% |
| Closing Price on April 28, 2026 | $1.90 |
| NeoTensr Startup Capital | ~$2 million |
Investor Eligibility and Next Steps
Investors who acquired Blaize securities during the defined class period are eligible to participate in the action without upfront fees, as representation is provided through a contingency fee arrangement. To serve as lead plaintiff—a role that grants significant influence over settlement negotiations and litigation strategy—investors must move the Court no later than October 5, 2026. The lead plaintiff is typically the investor with the largest financial interest in the relief sought who is adequate and typical of class members. Those who do not seek this role may still share in any eventual settlement or judgment as absent class members.
Interested parties can contact The Rosen Law Firm via Phillip Kim, Esq., at case@rosenlegal.com or by phone at 866-767-3653. Alternatively, investors may contact Kaplan Fox via email at pmayer@kaplanfox.com or by phone at (646) 315-9003. Investors may also contact Jim Baker at Johnson Fistel via email at jimb@johnsonfistel.com or by phone at (619) 814-4471, or Danielle Peyton at Pomerantz LLP via email at newaction@pomlaw.com or by phone at 646-581-9980, Ext. 7980.
How might the consolidation of multiple plaintiffs' firms impact Blaize Holdings' ability to negotiate a settlement before the October 5, 2026 lead plaintiff deadline?
What are the potential implications for Blaize's future revenue recognition policies if the court rules that the NeoTensr transaction was improperly recognized as revenue?
Could this litigation trigger a broader regulatory investigation into Blaize's other recent partnerships and revenue streams beyond the NeoTensr deal?




























